Literature DB >> 27784038

Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma.

Duy C Tran1, A Dimitrios Colevas2, Anne Lynn S Chang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27784038     DOI： 10.1001/jamadermatol.2016.3884

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  13 in total

1.  The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer.

Authors:  James Randall Patrinely; Anna K Dewan; Douglas B Johnson
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

Review 2.  Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma.

Authors:  J Claveau; J Archambault; D S Ernst; C Giacomantonio; J J Limacher; C Murray; F Parent; D Zloty
Journal:  Curr Oncol       Date:  2020-08-01       Impact factor: 3.677

Review 3.  Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.

Authors:  Dai Ogata; Tetsuya Tsuchida
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

Review 4.  Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.

Authors:  Enrico Zelin; Carlo Alberto Maronese; Arianna Dri; Ludovica Toffoli; Nicola Di Meo; Gianluca Nazzaro; Iris Zalaudek
Journal:  J Clin Med       Date:  2022-06-11       Impact factor: 4.964

5.  Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma.

Authors:  Marcos Oro-Ayude; Hae Jin Suh-Oh; Victor Sacristán-Santos; Patricia Vázquez-Bartolomé; Ángeles Flórez
Journal:  Case Rep Dermatol       Date:  2020-02-12

6.  Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation.

Authors:  Mireille L M van Baar; Alex D Guminski; Peter M Ferguson; Linda K Martin
Journal:  JAAD Case Rep       Date:  2019-05-25

Review 7.  Management of keratinocyte carcinoma - Special considerations in the elderly.

Authors:  Alison Bailey; Brooke Vasicek; Joy Tao; Monica Janeczek; Andia Mitri; Rebecca Tung
Journal:  Int J Womens Dermatol       Date:  2019-05-18

Review 8.  Immune checkpoint inhibitors to treat cutaneous malignancies.

Authors:  Dulce M Barrios; Mytrang H Do; Gregory S Phillips; Michael A Postow; Tomoko Akaike; Paul Nghiem; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-05-24       Impact factor: 11.527

Review 9.  Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas.

Authors:  Sean R Christensen
Journal:  F1000Res       Date:  2018-06-01

10.  Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma.

Authors:  Leandro J C Oliveira; Aline B L Gongora; Felipe G Barbosa; Carlos H Dos Anjos; Rodrigo R Munhoz
Journal:  J Immunother Cancer       Date:  2018-11-27       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.